Product Data Sheet

SARS-CoV-2-IN-38

Catalog No. A53388

main product photo
SARS-CoV-2-IN-38 is an inhibitor targeting the SARS-CoV-2 virus, demonstrating significant potential in antiviral research. This compound exhibits favorable oral bioavailability in murine models, achieving a bioavailability rate of 39.75%. It is relevant for studies focused on the development of therapeutics aimed at combating COVID-19 and related viral infections.
Chemical Information
Catalog NumA53388
M. Wt419.75
FormulaC18H14ClF4NO4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2882823-27-8
Synonyms
SMILESO=C(C(C)C)OC1=CC(F)=C(C=C1C(NC2=CC=C(C=C2)OC(F)(F)F)=O)Cl
Biological Activity
DescriptionSARS-CoV-2-IN-38 is an inhibitor targeting the SARS-CoV-2 virus, demonstrating significant potential in antiviral research. This compound exhibits favorable oral bioavailability in murine models, achieving a bioavailability rate of 39.75%. It is relevant for studies focused on the development of therapeutics aimed at combating COVID-19 and related viral infections.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.